Results 211 to 220 of about 7,465 (248)

Population pharmacokinetic modeling in radiopharmaceutical therapy: a review. [PDF]

Front Nucl Med
Hardiansyah D, Patrianesha BB, Glatting G.   +2 more
europepmc   +1 more source

²²⁵Ac-NOTA-trastuzumab human dosimetry using inter-radionuclide and biological half-life based allometric extrapolation method. [PDF]

EJNMMI Res
Almaslamani M, Kim K, Kim KI, Lim I, Kim HA, Woo SK.   +5 more
europepmc   +1 more source

Solving the limited availability of Astatine-211 from a European perspective: from production to the end user. [PDF]

EJNMMI Radiopharm Chem
Lindegren S, Jensen H, Van de Maele H, Mikolajczak R, Rabarijaona H, Aneheim E.   +5 more
europepmc   +1 more source

Editorial: Women in science - nuclear medicine 2024. [PDF]

Front Med (Lausanne)
Gutfilen B, Ramirez-Fort MK.
europepmc   +1 more source

Availability, accessibility, and economic feasibility of radionuclide therapies in Africa: a systematic review and quantitative infrastructure analysis. [PDF]

Front Nucl Med
Ibrahim EA.
europepmc   +1 more source

La-[^18/19F]fluoride complexes: a novel addition to the radiofluorination family.

Dalton Trans
Behe M, Gruber S, Li C, Schreckenbach G, Mu L, Schottelius M, Faizova R.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A brief history of the Society of Radiopharmaceutical Sciences

Nuclear Medicine and Biology, 2022
Heinz H Coenen
exaly   +5 more sources

Women in radiopharmaceutical/radiochemical sciences

Nuclear Medicine and Biology, 2022
Yearn Seong Choe, Danielle J Vugts
exaly   +3 more sources

Radiopharmaceutical Sciences

2020
Johannes Ermert, Martina Benesova, Verena Hugenberg   +2 more
exaly   +3 more sources

William C. Eckelman, an icon of radiopharmaceutical sciences

Nuclear Medicine and Biology, 2021
Albert D Windhorst
exaly   +3 more sources